Skip to content
NurExone logo
  • ABOUT
    • Company
    • Team
    • Board of Directors
    • Scientific Advisory Board
    • Advisory Committee
  • TECHNOLOGY
    • Learn About SCI
    • Extracellular Vesicles
    • siRNA-PTEN
    • IP
    • Study
  • PUBLICATIONS
    • Team Articles
    • Scientific Articles
  • COMMERCIAL
    • Potential Market
    • SCI Market
    • Transaction in the Exosome field
    • Product – Exo-PTEN
  • INVESTORS
  • NEWS & EVENTS
    • Press Releases
    • In The Media
    • Events
  • CAREER
  • CONTACT US
Menu
  • ABOUT
    • Company
    • Team
    • Board of Directors
    • Scientific Advisory Board
    • Advisory Committee
  • TECHNOLOGY
    • Learn About SCI
    • Extracellular Vesicles
    • siRNA-PTEN
    • IP
    • Study
  • PUBLICATIONS
    • Team Articles
    • Scientific Articles
  • COMMERCIAL
    • Potential Market
    • SCI Market
    • Transaction in the Exosome field
    • Product – Exo-PTEN
  • INVESTORS
  • NEWS & EVENTS
    • Press Releases
    • In The Media
    • Events
  • CAREER
  • CONTACT US

Press Releases

July 19, 2022

NurExone Exosomes to Be Used in Cutting Edge Molecular Research at Hebrew University’s Burstyn-Cohen Lab

Read More
July 13, 2022

NurExone Provides Corporate Update

Read More
July 11, 2022

NurExone to Collaborate with Polyrizon for Intranasal Administration of Cutting-Edge Exosome-Therapy

Read More
June 22, 2022

NurExone Biologic Inc. to Begin Trading on TSX Venture Exchange and Retains Market Maker

Read More
June 16, 2022

NurExone Biologic Inc. (Formerly, Enerspar Corp.) Announces Completion of Reverse Takeover Transaction

Read More
May 18, 2022

EnerSpar and NurExone Announce Conditional Acceptance of Proposed Reverse Takeover Transaction

Read More
March 15, 2022

EnerSpar and Israeli-Based Nurexone Provide Update on Progress to Closing RTO

Read More
August 30, 2021

EnerSpar and Israeli-Based Nurexone Announce RTO and New NI 43-101 Filed by EnerSpar

Read More
nurexone logo white and black

ABOUT

  • SCI
  • TBI
  • Exosome
  • PTEN
  • Team

Technology

  • General description
  • Exosome
  • siRNA-PTEN
  • Study results
  • IP

Contact Us

  • info@nurexone.com
Copyright © 2022 All rights reserved to NurExone
  • Career
  • Company
  • Contact Us
  • Description générale
  • Events
  • Exosome
  • Exosome Learn
  • Extracellular Vesicles
  • General Description
  • Home
  • In The Media
  • Investors
  • IP
  • Leadership
  • Leadership [fr]
  • Learn About SCI
  • Potential Market
  • Press Releases
  • Product – Exo-PTEN
  • PTEN
  • PTEN Learn
  • Sample Page
  • SCI
  • SCI Market
  • Scientific Articles
  • siRNA-PTEN
  • Study
  • TBI
  • Team Articles
  • Transaction in the Exosome filed

Set layout popup